bradykinin B2 antagonist

Icatibant companies

Answer

Public registers name 22 licence holders, 16 ingredient makers with a drug master file, 12 bulk ingredient labelers, 9 US labelers and 14 trial sponsors for Icatibant.

Each row is what a register states. A company named here is not endorsed or accused by this site.

MARKETING AUTHORISATION HOLDER

22 companies

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

ACCORD HEALTHCARE LIMITED
ICATIBANT ACCORD 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 20075/1455, Authorised Regulator MHRA
Accord Healthcare S.L.U.
Icatibant Accord (EMEA/H/C/005083), Authorised Regulator EMA
Accord Healthcare, Inc.
ICATIBANT INJECTION (DIN 02516608), Cancelled Pre Market Regulator Health Canada
AMAROX LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 49445/0406, Authorised Regulator MHRA
CELIX PHARMA LTD
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 53835/0005, Authorised Regulator MHRA
CIPLA (EU) LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 36390/0285, Authorised Regulator MHRA
FRESENIUS KABI LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 08828/0294, Authorised Regulator MHRA
GENERICS (UK) LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 04569/1838, Authorised Regulator MHRA
GENUS PHARMACEUTICALS LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 06831/0349, Authorised Regulator MHRA
GLENMARK PHARMACEUTICALS EUROPE LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 25258/0352, Authorised Regulator MHRA
JAMP PHARMA CORPORATION
ICATIBANT INJECTION (DIN 02547562), Marketed Regulator Health Canada
JUNO PHARMACEUTICALS CORP.
ICATIBANT INJECTION (DIN 02523337), Cancelled Pre Market Regulator Health Canada
MINT PHARMACEUTICALS INC
MINT-ICATIBANT (DIN 02524619), Approved Regulator Health Canada
PIRAMAL CRITICAL CARE LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 37071/0037, Authorised Regulator MHRA
SYNCHRONY PHARMA LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 39280/0034, Authorised Regulator MHRA
TAKEDA CANADA INC
FIRAZYR (DIN 02425696), Marketed Regulator Health Canada
Takeda Pharmaceuticals International AG
Firazyr (EMEA/H/C/000899), Authorised Regulator EMA
FIRAZYR 30 MG SOLUTION FOR INJECTION IN PRE FILLED SYRINGE, PLGB 54937/0004, Authorised Regulator MHRA
TEVA CANADA LIMITED
TEVA-ICATIBANT (DIN 02513773), Cancelled Pre Market Regulator Health Canada
TEVA UK LIMITED
ICATIBANT TEVA 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 00289/2476, Authorised Regulator MHRA
UNIVERSAL FARMA, S.L.
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 19706/0010, Authorised Regulator MHRA
USV UK LIMITED
ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 32870/0082, Authorised Regulator MHRA
WOCKHARDT UK LIMITED
ICATIBANT 30MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 29831/0725, Authorised Regulator MHRA

API MANUFACTURER

16 companies

Filed a drug master file with FDA for the active ingredient.

ALEMBIC PHARMACEUTICALS LTD
DMF 34450, type II, active, submitted 2020-02-06 Regulator FDA drug master file list
AMBIO INC
DMF 29225, type II, active, submitted 2015-05-22 Regulator FDA drug master file list
AURO PEPTIDES LTD
DMF 33750, type II, active, submitted 2019-04-03 Regulator FDA drug master file list
BACHEM AG
DMF 20862, type II, active, submitted 2007-09-17 Regulator FDA drug master file list
BCN PEPTIDES SA
DMF 29213, type II, active, submitted 2015-03-26 Regulator FDA drug master file list
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
DMF 30526, type II, active, submitted 2016-09-27 Regulator FDA drug master file list
CHENGDU SHENGNUO BIOPHARM CO LTD
DMF 28496, type II, active, submitted 2015-03-09 Regulator FDA drug master file list
CIPLA LTD
DMF 32318, type II, active, submitted 2018-01-08 Regulator FDA drug master file list
DR REDDYS LABORATORIES LTD
DMF 32156, type II, active, submitted 2017-10-30 Regulator FDA drug master file list
FRESENIUS KABI IPSUM SRL
DMF 38190, type II, active, submitted 2024-06-24 Regulator FDA drug master file list
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
DMF 31106, type II, active, submitted 2016-12-16 Regulator FDA drug master file list
MATRIX PHARMACORP PRIVATE LTD
DMF 31260, type II, active, submitted 2016-12-29 Regulator FDA drug master file list
MSN LIFE SCIENCES PRIVATE LTD
DMF 30672, type II, active, submitted 2016-07-25 Regulator FDA drug master file list
Sun Pharmaceutical Industries Ltd.
DMF 31550, type II, active, submitted 2018-03-30 Regulator FDA drug master file list
TAPI NL BV
DMF 30476, type II, active, submitted 2016-06-09 Regulator FDA drug master file list
USV PRIVATE LTD
DMF 33212, type II, active, submitted 2018-12-07 Regulator FDA drug master file list

BULK INGREDIENT LABELER

12 companies

Lists the bulk active ingredient with FDA (NDC directory).

AMBIOPHARM INC
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
Assia Chemical Industries Ltd - Teva Tech Site
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
Aurobindo Pharma Limited
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
BACHEM AG
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
BCN PEPTIDES SA
Icatibant acetate, BULK INGREDIENT Regulator openFDA
CHENGDU SHENGNUO BIOPHARM CO LTD
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
Dr.Reddy's laboratories Limited
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
FRESENIUS KABI IPSUM SRL
ICATIBANT ACETATE, BULK INGREDIENT Regulator openFDA
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
MSN Life Sciences Private Limited
Icatibant Acetate, BULK INGREDIENT Regulator openFDA
SUN PHARMACEUTICAL INDUSTRIES INC
Icatibant acetate, BULK INGREDIENT Regulator openFDA
USV Private Limited
Icatibant Acetate, BULK INGREDIENT Regulator openFDA

US LABELER

9 companies

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

Alembic Pharmaceuticals Inc.
Icatibant, ANDA Regulator openFDA
Alembic Pharmaceuticals Limited
Icatibant, ANDA Regulator openFDA
Cipla USA, Inc.
ICATIBANT, ANDA Regulator openFDA
Cycle Pharmaceuticals Ltd-Uk
SAJAZIR, ANDA Regulator openFDA
Eugia US LLC
Icatibant, ANDA Regulator openFDA
Fresenius Kabi USA, LLC
Icatibant, ANDA Regulator openFDA
Hikma Pharmaceuticals USA Inc.
Icatibant, ANDA Regulator openFDA
Takeda Pharmaceuticals America, Inc.
Firazyr, NDA Regulator openFDA
Teva Pharmaceuticals USA, Inc
Icatibant, ANDA Regulator openFDA

TRIAL SPONSOR

14 companies

Sponsors registered clinical trials of the peptide.

Shire
9 registered trials Trial register ClinicalTrials.gov
Vanderbilt University Medical Center
5 registered trials Trial register ClinicalTrials.gov
Takeda
4 registered trials Trial register ClinicalTrials.gov
Pharvaris Netherlands B.V.
3 registered trials Trial register EU CTIS
Belfast Health and Social Care Trust
1 registered trial Trial register ClinicalTrials.gov
GCS Ramsay Santé pour l'Enseignement et la Recherche
1 registered trial Trial register ClinicalTrials.gov
KalVista Pharmaceuticals, Ltd.
1 registered trial Trial register ClinicalTrials.gov
Massachusetts General Hospital
1 registered trial Trial register ClinicalTrials.gov
Nang Kuang Pharmaceutical Co., Ltd.
1 registered trial Trial register ClinicalTrials.gov
Oslo University Hospital HF
1 registered trial Trial register EU CTIS
QuantumLeap Healthcare Collaborative
1 registered trial Trial register ClinicalTrials.gov
Sanofi
1 registered trial Trial register ClinicalTrials.gov
Sebastian Videla
1 registered trial Trial register ClinicalTrials.gov
Technical University of Munich
1 registered trial Trial register ClinicalTrials.gov

Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings. Trade between countries in all polypeptide hormones, Icatibant among them: trade.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.